Overview
Norepinephrine Addition in Spinal Anesthesia of Caesarean Section
Status:
Recruiting
Recruiting
Trial end date:
2022-04-01
2022-04-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The objective is to compare efficacy of prophylactic norepinephrine bolus versus Infusion in prevention of hypotension which occurs frequently after spinal anesthesia for caesarean section. The authors hypothesize that prophylactic norepinephrine bolus is as effective as infusion in Prevention of hypotension after spinal anesthesia in caesarean sectionPhase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Fayoum University HospitalTreatments:
Norepinephrine
Pharmaceutical Solutions
Criteria
Inclusion Criteria:- 18 - 45 years
- American Society of Anesthesiologists physical status classification II or III
- Elective caesarean section under spinal anesthesia
- Normal singleton pregnancy beyond 36 weeks gestation
- Weight 50-100 kg, height 150-180 cm
Exclusion Criteria:
- Patient refusal
- Allergy or hypersensitivity to norepinephrine
- Diabetes, excluding gestational diabetes
- Preexisting or pregnancy-induced hypertension
- Arrhythmia
- Cerebrovascular disease
- Known fetal abnormality or fetal distress
- Any contraindication to spinal anesthesia
- Use of monoamine oxidase inhibitors, triptyline or imipramine antidepressants